Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
1.895
-0.295 (-13.47%)
At close: Mar 5, 2026, 4:00 PM EST
1.870
-0.025 (-1.32%)
Pre-market: Mar 6, 2026, 8:34 AM EST
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $184.99 million as of March 6, 2026. Its market cap has decreased by -29.98% in one year.
Market Cap
184.99M
Enterprise Value
38.99M
1-Year Change
-29.98%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $184.99M, a decrease of -71.53%. That is a compound annual growth rate of -11.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 185.00M | -7.55% |
| Dec 31, 2025 | 200.10M | 90.94% |
| Dec 31, 2024 | 104.80M | -87.33% |
| Dec 29, 2023 | 827.40M | 35.66% |
| Dec 30, 2022 | 609.90M | -66.42% |
| Dec 31, 2021 | 1.82B | -58.45% |
| Dec 31, 2020 | 4.37B | 187.69% |
| Dec 31, 2019 | 1.52B | 39.66% |
| Dec 31, 2018 | 1.09B | -15.40% |
| Dec 29, 2017 | 1.29B | 122.48% |
| Dec 30, 2016 | 577.90M | -11.05% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Heron Therapeutics | 192.31M |
| Compugen | 191.75M |
| Molecular Partners AG | 188.64M |
| Tiziana Life Sciences | 183.78M |
| NeOnc Technologies Holdings | 183.64M |
| SAB Biotherapeutics | 181.38M |
| Kalaris Therapeutics | 180.95M |
| Cartesian Therapeutics | 178.90M |